Tumor necrosis factor-alpha in patients with malaria

Area of Science:

• Immunology
• Infectious Diseases
• Biochemistry

Background:

• Malaria remains a significant global health challenge, with varying severity depending on the Plasmodium species.
• Tumor Necrosis Factor-alpha (TNF-alpha) is a pro-inflammatory cytokine implicated in the pathogenesis of severe malaria.
• Understanding the role of TNF-alpha in different malaria infections is crucial for prognosis.

Purpose of the Study:

• To investigate the correlation between serum TNF-alpha levels and malaria severity.
• To evaluate TNF-alpha as a prognostic marker in malaria patients.
• To compare TNF-alpha concentrations across different Plasmodium species infections.

Main Methods:

• Serum samples from 54 malaria patients were analyzed for TNF-alpha concentration using avidin-biotin sandwich ELISA.
• Patients included Plasmodium falciparum, P. vivax, P. malariae, P. ovale, and mixed infections.
• Correlation between TNF-alpha levels, parasitemia, and clinical outcomes (including fatal outcomes) was assessed.

Main Results:

• Serum TNF-alpha levels were significantly elevated in Plasmodium falciparum infections compared to P. vivax.
• Higher TNF-alpha concentrations were observed in fatal malaria cases.
• A positive correlation was found between the degree of parasitemia and TNF-alpha production.
• Mean TNF-alpha levels in P. falciparum and P. vivax infections were 915 pg/ml and 280.6 pg/ml, respectively, significantly higher than controls (12.9 pg/ml).

Conclusions:

• Serum TNF-alpha concentration is a reliable indicator of malaria severity.
• Elevated TNF-alpha levels can serve as an important prognostic marker for malaria.
• The study highlights the critical role of TNF-alpha in the pathophysiology of severe malaria.